Phio Pharmaceuticals Announces Positive Pathology Results: Final Maximum Dose Cohort for INTASYL PH-762 Skin Cancer Trial
King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-11-03 7:45 AM EST | Phio Pharmaceuticals Corp.
Britannia Life Sciences Inc. Enters into $11.3 Million Share Exchange Agreement with McEwen Inc. and Britannia Mining Solutions Inc.
Toronto, Ontario--(Newsfile Corp. - November 3, 2025) - Britannia Life Sciences Inc. (CSE: BLAB) ("Britannia" or the "Company") is pleased to announce that it has entered into a share exchange agreement (the "Agreement") with McEwen Inc. ("McEwen") and Britannia Mining Solutions Inc. (doing business as Paragon Geochemical Laboratories Inc.) (together, "Paragon"). Pursuant to the terms of the Agreement, McEwen will acquire 648,002 common shares of Paragon from Britannia at a deemed price
Biotechnology, Household / Consumer / Cosmetics, Health, Cannabis Ancillary Service Provider
2025-11-03 7:07 AM EST | Britannia Life Sciences Inc
Conexeu Sciences Appoints Miles Harrison as President & Chief Executive Officer, to Shape the Future of True Tissue Regeneration
Reno, Nevada--(Newsfile Corp. - November 3, 2025) - Conexeu Sciences Inc. ("Conexeu" or the "Company"), a pre-commercial biotechnology company redefining regenerative medicine through next-generation collagen science, announces the appointment of Miles D. Harrison as President & Chief Executive Officer of the Company. He has also been appointed to the Company's Board of Directors. At Conexeu, Miles will lead the Company's next phase of growth, advancing its first-in-class col
Healthcare and Hospitals, Pharmaceuticals, Health
2025-11-03 7:00 AM EST | Conexeu Sciences Inc.
Cosmo Receives CE Certification for ColonPRO EU - The Most Advanced AI Software Platform for Colonoscopy in Europe
Dublin, Ireland--(Newsfile Corp. - November 3, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that ColonPRO EU, the Company’s next-generation artificial intelligence software for colonoscopy, has received CE certification. Following FDA clearance in the United States, this certification brings to Europe the most advanced AI-assisted colonoscopy platform ever developed. The system has already
Healthcare and Hospitals, Health
2025-11-03 12:59 AM EST | Cosmo Pharmaceuticals N.V.
Mobile-health Network Solutions Reports FY2025 Results and Operational Update
Singapore, Singapore--(Newsfile Corp. - October 31, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced its financial results for the fiscal year ended June 30, 2025 ("FY2025"), and outlined its strategy to scale its proprietary AI-driven virtual-care platform across high-growth emerging markets. During FY2025, the Company completed its transition from an asset-heavy structure to an asset-li
2025-10-31 4:30 PM EDT | Mobile-health Network Solutions
Phio Pharmaceuticals Announces Appointment of Mr. David H. Deming to the Position of Lead Independent Director
King of Prussia, Pennsylvania--(Newsfile Corp. - October 31, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio is pleased to announce that David Deming has been appointed Lead Independent Director of the Board of Directors of Phio Pharmaceuticals. Mr. Deming brings over 30 years of experience in investment bankin
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-10-31 10:15 AM EDT | Phio Pharmaceuticals Corp.
Republic Technologies Provides Corporate Updates for Q3 and Outlooks for Q4
Vancouver, British Columbia--(Newsfile Corp. - October 31, 2025) - Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (WKN: A41AYF) (the "Company" or "Republic") is pleased to provide this comprehensive news release outlining recent management updates, corporate developments, and business strategies for Q2 and Q3 2025. Management Update At the Company's Annual General and Special Meeting held on August 9, 2025, Republic announced the appointment of
Technology, Pharmaceuticals, Health
2025-10-31 2:00 AM EDT | Republic Technologies Inc.
Republic Technologies gibt Unternehmensupdates für Q3 und Ausblick auf Q4 bekannt
Vancouver, British Columbia--(Newsfile Corp. - Freitag, 31. Oktober 2025) - Republic Technologies Inc. (CSE: DOCT) (FSE: 7FM0) (WKN: A41AYF) (das "Unternehmen" oder "Republic") freut sich, diese umfassende Pressemitteilung zu veröffentlichen, die aktuelle Management-Updates, Unternehmensentwicklungen und Geschäftsstrategien für das zweite und dritte Quartal 2025 zusammenfasst. Management-Update Auf der Jahres- und Sonderhauptversammlung des Unternehmen
Technology, Pharmaceuticals, Health
2025-10-31 2:00 AM EDT | Republic Technologies Inc.
Hemostemix's Boots on the Ground in Florida October Update
Calgary, Alberta--(Newsfile Corp. - October 30, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from pain related to angina, peripheral arterial disease, chronic limb threatening ischemia, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, today announced major progress in Flori
Biotechnology, Pharmaceuticals, Health
2025-10-30 11:29 AM EDT | Hemostemix Inc.
BioHarvest Sciences Announces Strategic CDMO Partnership to Revolutionize Saffron Compound Production with Botanical Synthesis
British Columbia and Rehovot, Israel--(Newsfile Corp. - October 30, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a biotechnology company pione
Biotechnology, Pharmaceuticals, Health
2025-10-30 7:30 AM EDT | BioHarvest Sciences Inc.
PreveCeutical Closes Second Tranche of Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - October 30, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases of August 5, 2025, September 5, 2025 and October 10, 2025 it has closed a second tranche (the "Second Tranche
Biotechnology, Pharmaceuticals, Health
2025-10-30 7:00 AM EDT | PreveCeutical Medical Inc.
Quantum BioPharma Ltd. Announces Corporate Updates
Toronto, Ontario--(Newsfile Corp. - October 29, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces, as approved by the shareh
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-10-29 9:00 PM EDT | Quantum BioPharma Ltd.
Microbiome Labs Expands Portfolio with Launch of Women's Health Line
Franklinton, North Carolina--(Newsfile Corp. - October 29, 2025) - Microbiome Labs, a leader in microbiome-based solutions, today announced the launch of its new Women's Health line. The collection debuts with two targeted formulations - Vaginal Balance and Pregnancy Support - designed to promote women's health through probiotic and nutrient blends with clinical evidence behind the ingredients. For decades, the gut has dominated the probiotic conversation. But another microbiome is crit
2025-10-29 11:40 AM EDT | Microbiome Labs
Apollo Biowellness, Inc., Corporate Status and Merger Update
North Bergen, New Jersey--(Newsfile Corp. - October 29, 2025) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company"), is pleased to announce it is updating its shareholders on various developments and updates on both corporate developments and an update on the merger with Revive Regenerative, Inc. The Company will continue to update and will provide more information and greater detail over the next few weeks. In the future, we will have an update and status on the consumer based bio
Household / Consumer / Cosmetics, Health
2025-10-29 9:30 AM EDT | Apollo Biowellness, Inc.
KATALYST & Co. Healthcare Transformation Platform Launches with $10 Million in Funding
Palm Beach, Florida--(Newsfile Corp. - October 29, 2025) - Kat Marie Alvarez, RN, MBA, a nationally recognized healthcare leader, today announced the launch of KATALYST & Co., an integrated platform that unites strategic advisory services, capital deployment, and global operational execution. The company begins operations with $10 million in funding to drive its mi
Healthcare and Hospitals, Insurance, Investment Banking, Health
2025-10-29 8:30 AM EDT | KATALYST & Co.
Hemostemix Announces Its Webinar for Florida Vascular Surgeons: Autologous Stem Cell Therapy for CLTI
Calgary, Alberta--(Newsfile Corp. - October 28, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from pain related to angina, peripheral arterial disease, chronic limb threatening ischemia, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and total body ischemia, is pleased to announce a one-hour educa
Biotechnology, Pharmaceuticals, Health
2025-10-28 3:44 PM EDT | Hemostemix Inc.
Adia Nutrition Thrilled to Announce to Shareholders Early Q3 Financials Release and Remarkable 200%+ Revenue Growth
Winter Park, Florida--(Newsfile Corp. - October 28, 2025) - Adia Nutrition (OTCQB: ADIA) is thrilled to announce the early release of its Q3 financial results, a powerful testament to the exceptional organization and unwavering commitment of our dynamic team. By unveiling these results weeks ahead of schedule, Adia Nutrition reinforces its dedication to transparency, operational excellence, and industry leadership, while delivering a financial performance that redefines success. Adia Nu
Healthcare and Hospitals, Health
2025-10-28 9:30 AM EDT | Adia Nutrition Inc.
Izotropic Launches "Breast Imaging News" Page on BreastCT.com
Sacramento, California--(Newsfile Corp. - October 28, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses, and treatment of breast cancers, is pleased to announce the launch of the "Breast Im
2025-10-28 8:00 AM EDT | Izotropic Corporation
Glow Lifetech Reduces Warrant Overhang by 20+ Million as Largest Shareholder Exercises $450k+ At-the-Money Warrants, Bolstering Balance Sheet
Toronto, Ontario--(Newsfile Corp. - October 28, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce that it has further strengthened its balance sheet and simplified its capital structure through the recent exercise and expiry of a combined 20 million common share purchase warrants ("Warrants"). These developments reflect continued shareholder confidence in the Company's long-term growth strategy and commitment to di
2025-10-28 7:30 AM EDT | Glow Lifetech Corp.
IR-MED's Key Clinical and Media Milestones
Rosh Pina, Israel--(Newsfile Corp. - October 27, 2025) - IR-Med Inc. (OTCQB: IRME), (the "Company" or "IR-Med"), a medical technology company developing a non-invasive, AI-powered infrared spectroscopy platform for the assessment of pressure injuries and diabetic ulcers, today announced a series of recent milestones that highlight the Company's expanding visibility within the healthcare, investment, and media communities. Podium Presentation at Magnet & Pathway 2025 Confer
Technology, Biotechnology, Healthcare and Hospitals, Health
2025-10-27 4:05 PM EDT | IR-MED, Inc.